Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Yamanouchi discovers naturally occurring cytotoxic depsipeptide

Sep. 8, 2000

Pharmacia's Aromasin receives clearance from Health Canada

Sep. 7, 2000

Bayer investigates inhibition of raf kinase signaling pathway as new approach to cancer

Sep. 6, 2000

New antitumor compound from Banyu produced by microorganism

Sep. 5, 2000

MEK inhibitors and their use described in recent patents

Sep. 5, 2000

PARP inhibitors reportedly useful in combination with cytotoxic agents

Sep. 5, 2000

Taxotere combination therapy approved in E.U. for treatment of advanced breast cancer

Sep. 5, 2000

SuperGen updates progress of phase III rubitecan trials

Sep. 4, 2000

Arimidex approved by FDA as first-line therapy of breast cancer

Sep. 4, 2000

Cytogen and Northwest Biotherapeutics execute PSMA sublicense agreement

Sep. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...